Overview

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A Single Dose Study of GRC 27864 in Healthy Volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Glenmark Pharmaceuticals Ltd. India
Collaborator:
Glenmark Pharmaceuticals S.A.
Treatments:
Celecoxib